C-Peptide and Its C-Terminal Fragments Improve Erythrocyte Deformability in Type 1 Diabetes Patients

Table 3

Erythrocyte elongation index (EI) (%) in the shear stress range 0.6–12 Pa for different treatment groups, 𝑛=23.

Shear stress
	0.6 Pa	1.2 Pa	3 Pa	6 Pa	12 Pa
Healthy controls	5.87±0.72^∗	14.37±0.61^∗	29.08±0.79^∗	39.19±1.02^∗	45.93±0.85^∗
Diabetes patients	4.38±0.63	11.77±0.49	26.01±0.60	35.48±0.84	43.34±0.92
C-peptide	5.40±0.82^∗	14.11±0.85^∗	28.34±1.58^∗	39.07±1.46^∗	45.82±1.43^∗
HP	5.77±0.81^∗	14.18±1.17^∗	28.61±1.37^∗	38.49±1.62^∗	45.82±1.81^∗
PP	6.12±0.93^∗	14.02±1.37^∗	28.23±1.46^∗	38.85±1.54^∗	45.20±1.74^∗
MF	4.42±0.89	11.39±1.07	25.82±1.24	35.79±0.98	43.39±1.17
SCR	4.10±0.91	11.25±1.07	25.58±1.07	35.64±0.91	43.48±1.00

^∗𝑃<.01 versus type 1 diabetes patients.